Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb;32(2):306-319.
doi: 10.1038/s41418-024-01385-4. Epub 2024 Oct 3.

DNA damage-inducible transcript 3 positively regulates RIPK1-mediated necroptosis

Affiliations

DNA damage-inducible transcript 3 positively regulates RIPK1-mediated necroptosis

Rui Ni et al. Cell Death Differ. 2025 Feb.

Abstract

DNA damage-inducible transcript 3 (DDIT3) is a well-known transcription factor that regulates the expression of apoptosis-related genes for promoting apoptosis during endoplasmic reticulum stress. Here, we report an unrecognized role of DDIT3 in facilitating necroptosis. DDIT3 directly binds and competitively prevents the p38 MAPK-MK2 interaction and thereby blocking MK2 activation while stimulating p38 MAPK activation. This blockage of MK2 activation initially prevents RIPK1 phosphorylation at Ser320 (inactivation), subsequently relieving its suppression of RIPK1 activation. Consequently, p38 MAPK facilitates RIPK1 phosphorylation at Ser166 (activation) through DDIT3 phosphorylation-related mechanisms, leading to necroptosis. Mechanistically, a 10-amino acid segment (Glu19-Val28) within DDIT3's N-terminus is identified to account for its pro-necroptotic function. In vivo studies demonstrate that forced expression of DDIT3 induces necroptosis, whereas deletion of DDIT3 alleviates necroptosis in mouse hearts under stress. These findings shed light on a novel regulatory mechanism by which DDIT3 promotes RIPK1 activation and subsequent necroptosis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests. Ethical approval: All mouse experimental procedures were approved by the Animal Use Subcommittee at the University of Western Ontario, Canada (protocol numbers: 2021-054 and 2020-047), and Soochow University, China (protocol number: 2017-0043). All methods were performed in accordance with the relevant guidelines and regulations.

References

    1. Guo X, Chen Y, Liu Q. Necroptosis in heart disease: molecular mechanisms and therapeutic implications. J Mol Cell Cardiol. 2022;169:74–83. - PMC - PubMed
    1. Dondelinger Y, Delanghe T, Rojas-Rivera D, Priem D, Delvaeye T, Bruggeman I, et al. MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death. Nat Cell Biol. 2017;19:1237–47. - PubMed
    1. Jaco I, Annibaldi A, Lalaoui N, Wilson R, Tenev T, Laurien L, et al. MK2 phosphorylates RIPK1 to prevent TNF-induced cell death. Mol Cell. 2017;66:698–710.e5. - PMC - PubMed
    1. Linkermann A, Hackl MJ, Kunzendorf U, Walczak H, Krautwald S, Jevnikar AM. Necroptosis in immunity and ischemia-reperfusion injury. Am J Transplant. 2013;13:2797–804. - PubMed
    1. Guo Y, Zhou J, Wang Y, Wu X, Mou Y, Song X. Cell type‐specific molecular mechanisms and implications of necroptosis in inflammatory respiratory diseases. Immunol Rev. 2023;321:imr.13282. - PubMed

MeSH terms

Substances

LinkOut - more resources